Rapid test detection of anti-infliximab antibodies: performance comparison with three different immunoassays

BACKGROUND AND AIMS: Therapeutic drug monitoring (TDM) of infliximab (IFX) and anti-infliximab antibodies (ATIs) is essential for treatment optimisation in inflammatory bowel disease (IBD) patients. The aim of this study was to estimate and compare the agreement and accuracy between a new rapid test...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocha, Cátia, Lago, Paula, Fernandes, Samuel, Correia, Luís, Portela, Francisco, Vieira, Ana Isabel, Patita, Marta, Arroja, Bruno, Ministro, Paula, Alves, Catarina, Dias, Cláudia Camila, Magro, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682213/
https://www.ncbi.nlm.nih.gov/pubmed/33281935
http://dx.doi.org/10.1177/1756284820965790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682213/
https://www.ncbi.nlm.nih.gov/pubmed/33281935
http://dx.doi.org/10.1177/1756284820965790

Ejemplares similares